Blake Byers
blakebyers.com · 561 words · saved by 2 readers
Building and investing in Longevity, Foundation Models, AI Drug Development, AI Robots, Codegen, and Brain Computer Interfaces.
I work on projects that can positively bend the arc of humanity over multiple generations, or are just fun, ideally both. Please reach out, my email is not that hard to find. Twitter @byersblake. Investing I am an avowed generalist. I’ve backed early stage companies across personal finance, cancer treatments, quantum computing, blood screening, and enterprise software that have all gone public. My current investments include superintelligence, mathematical reasoning, coding agents, AI drug development, brain computer interfaces and human longevity. Neuralink - Series B. Brain computer…
saved by
related reading
- AI 2027ai-2027.com
- Requests for Startups | Y Combinatorycombinator.com
- Amaranth Foundation - Longevity and Neuroscienceamaranth.foundation
- near.blognear.blog
- AI 2027ai-2027.com
- Merge Labsmerge.io
- Starbloom Capitalstarbloom.capital
- Convictionconviction.com
- List of Biotechnology Companies to Watch – AI Expanded Versionsubstack.com
- Sam Altman invested $180 million into a company trying to delay death | MIT Technology Reviewtechnologyreview.com
- Elad Gileladgil.com
- Colossuscolossus.com